Skip to NavigationSkip to content

False Claims Act

US DoJ launch investigation into Acadia Pharmaceuticals

Image Credit: Another Believer

The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia Pharmaceuticals in relation to Nuplazid, a psychosis drug for those with Parkinson’s disease.

Nuplazid, an antipsychotic for those suffering from hallucinations and delusions with Parkinson’s, received FDA approval in 2016.

Pfizer to pay $784.6 million fine due to Wyeth Medicaid fraud

Pfizer has agreed to pay $784.6 million in a settlement with the US Department of Justice, relating to false and fraudulent prices charged by Wyeth, a company Pfizer purchased in 2009.

The claim that Wyeth knowingly reported to the government false and fraudulent prices on two of its proton pump inhibitors (PPI) drugs, Protonix Oral and Protonix IV, was not denied by Wyeth and Pfizer.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches